Eurepa-V 1/0.3 Tablet (Repaglinide 1mg / Voglibose 0.3mg)

Eurepa-V 1/0.3 Tablet 10’s is a combination drug that belongs to the anti-diabetic class. It is primarily used to treat Type 2 diabetes. Type 2 diabetes is a common condition that causes the level of glucose (sugar) in the blood to become too high. It’s a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines and have regular check-ups to lead a normal life.

Eurepa-V 1/0.3 Tablet 10’s is composed of two medicines, namely Repaglinide and voglibose. Repaglinide increases the amount of insulin released by the pancreas by stimulating the pancreas to release insulin to your body and helps regulate the amount of glucose (sugar) in the blood. Voglibose helps control the amount of glucose (sugars) in the blood by inhibiting the intestinal enzyme (alpha-glucosidase) and delaying the digestion and absorption of carbohydrates in the intestine. Altogether, they prevent blood sugar from rising very high after meals.

Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning. The dosage is based on your medical condition and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day. Tell your doctor if your condition does not improve or worsens (if your blood sugar is too high or too low). In some cases, you may experience certain common side effects, such as Hypoglycaemia, Allergy/ Skin Reactions, Stomach Pain, Diarrhoea, Abdominal Pain, Heartburn, Nausea, and Vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Before taking this medication, tell your doctor or pharmacist if you are allergic to Repaglinide and voglibose; or have other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Eurepa-V 1/0.3 Tablet 10’s should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking Eurepa-V 1/0.3 Tablet 10’s abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy), and nerve damage (neuropathy). Eurepa-V 1/0.3 Tablet 10’s should not be taken if you have type 1 diabetes mellitus, severe kidney, or liver disease. During pregnancy/lactation, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

• Used in the adult over 18 years of age and for treating patients with type 2 Diabetes.

Eurepa-V 1/0.3 Tablet 10’s is composed of two medicines, namely Repaglinide and voglibose. Repaglinide increases the amount of insulin released by the pancreas by stimulating the pancreas to release insulin to your body and helps regulate the amount of glucose (sugar) in the blood. Voglibose helps control the amount of glucose (sugars) in the blood by inhibiting the intestinal enzyme (alpha-glucosidase) and delaying the digestion and absorption of carbohydrates in the intestine. Altogether, they prevent blood sugar from rising very high after meals.

Related Product

Take this medication as directed by your doctor. The dosage is based on your medical condition and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day.

Store in a cool and dry place away from sunlight

• Low blood sugar (hypoglycaemia)
• Upper respiratory infection
• Flu-like symptoms
• Back pain
• Joint pain
• Dizziness
• Skin rash or allergic reactions on the skin
• Indigestion or delayed digestion
• Loss of appetite
• Stomach ache or stomach upset
• Diarrhoea
• Blurred vision
• Feeling of restlessness
• Feeling restless
• Weakness or fatigue